A Randomized, Double-blind, Placebo-controlled, 2-Period Crossover Study Evaluating Effect Of Pregabalin In Patients With Fibromyalgia And Sleep Maintenance Disturbance
Latest Information Update: 22 Feb 2017
Price :
$35 *
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia; Sleep disorders
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 May 2011 Results presented at the 30th Annual Scientific Meeting of the American Pain Society.
- 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 08 Nov 2010 New trial record